Navigation Links
New Vaccine to Bring Dramatic Decrease in Cervical Cancer Deaths

GlaxoSmithKline has reported that its experimental vaccine against a virus that causes cervical cancer could bring about a decrease in the number// of cases and deaths from the illness by up to 76 percent.

Their vaccine, Cervarix prevents the infection from two strains of the human papillomavirus (HPV) which is responsible for about 70 percent of cases of cervical cancer.

At a medical conference in Prague researchers who undertook a computer model study funded by GlaxoSmithKline predicted the impact the vaccine would have in Britain if all 12 year-old girls were vaccinated.

According to them if coverage was 100 percent, the company claimed that it could lead to a decrease in deaths by 76 percent. The research revealed that eighty percent vaccine coverage could reduce cases and deaths by 61 percent.

The researchers said, "Over the lifetime of a UK cohort of 12 year old females, the model predicts the occurrence of 2,636 cervical cancer cases and 1,403 cancer deaths without vaccination. With vaccination at 100 percent coverage, the forecast would be as low as 632 cancer cases (76 percent reduction) and 335 cancer deaths (also 76 percent reduction)."

These estimates have been made based on the vaccination being paired with the existing cervical screening program. Dr Anne Szarewski, of the charity Cancer Research UK, said HPV vaccination offers hope of reducing cases and preventing deaths from the illness.

She said, "Currently there are 3,000 women in the UK who get cervical cancer each year -- despite a highly efficient screening program."

Competing drug manufacturer Merck & Co Inc has also produced a vaccine to prevent cervical cancer. Their vaccine, Gardasil has been recommended by the European Medicines Agency to prevent cancer caused by four strains of HPV. The U.S. Food and Drug Administration in June has approved it.


Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:

(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
Breaking Medicine Technology: